Skip to content
Certified ManufacturersFor manufacturers

Icelandirect LLC d/b/a Soma Labs, Inc.

Middlesex, NJ, United States

Due-diligence report

Find an accredited testing lab and confirm its scope covers your product and methods.

Icelandirect LLC d/b/a Soma Labs, Inc. is a dietary supplement manufacturer in Middlesex, NJ, United States, certified to NSF/ANSI 455-2 GMP, with 1 manufacturing facility on NSF’s public NSF/ANSI 455 listing as of November 19, 2026. Listed dosage forms: capsules, powders, softgels and tablets.

Facilities listed
1
Last checked

Dosage forms

As listed in the product categories of this company’s NSF/ANSI 455-2 certified facilities.

Certified facilities

Manufacturing (1)

  • 252 Wagner Street, Middlesex, NJ 08846, United States

    • Coating
    • Dry Formulation
    • Encapsulation
    • Mixing
    • Packaging/Labeling Operation
    • Packaging/Labeling Operation - Bulk Packaging
    • Packaging/Labeling Operation - Primary Packaging
    • Packaging/Labeling Operation - Secondary Packaging
    • Quality Unit Operations
    • Tablet Compression
    • Warehousing

How Icelandirect LLC d/b/a Soma Labs, Inc. compares

Among the 769 manufacturers we list, as of our last check.

FDA recall records

No food or dietary supplement recall found under the name Icelandirect LLC d/b/a Soma Labs, Inc. in FDA’s enforcement reports, as of .

We match FDA records by company name only. A recall listed under a different name won’t appear here, and a different company with the same name could. FDA’s food enforcement records start in June 2012. How we check

FDA inspections

FDA lists 9 food or dietary supplement inspections at facilities matching Icelandirect LLC d/b/a Soma Labs, Inc., from 2010 to 2024, as of . 3 found no objectionable conditions, 4 found conditions the firm was left to correct, and 2 led FDA to recommend official action.

  • No action indicated · No objectionable conditions found

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    FEI 3002716640

  • No action indicated · No objectionable conditions found

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    FEI 3002716640

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    6 citations posted:

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Tests, examinations - scientifically valid (21 CFR 111.75(h))
    • Specifications not met - reject, quality control (21 CFR 111.77(a))
    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))
    See all 6 citations
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Specifications not met - reject, quality control (21 CFR 111.77(a))

      Your quality control personnel did not reject a component for which a specification was not met.

    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.

    • Laboratory operations: electronic (21 CFR 111.325(a))

      Your electronic records for your laboratory operations do not comply with the electronic records requirements.

    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))

      You did not perform manufacturing operations under conditions and controls that protect against the potential for contamination.

    FEI 3002716640

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    5 citations posted:

    • Specifications met - contamination limits (21 CFR 111.73)
    • Specifications not met - reject, quality control (21 CFR 111.77(a))
    • Written procedures - quality control operations (21 CFR 111.103)
    • Document - material review, disposition (21 CFR 111.113(c))
    See all 5 citations
    • Specifications met - contamination limits (21 CFR 111.73)

      You did not determine whether you met established limits on contamination that may adulterate, or that may lead to adulteration of, the finished batch of the dietary supplement.

    • Specifications not met - reject, quality control (21 CFR 111.77(a))

      Your quality control personnel did not reject a component for which a specification was not met.

    • Written procedures - quality control operations (21 CFR 111.103)

      You did not follow written procedures for quality control operations.

    • Document - material review, disposition (21 CFR 111.113(c))

      The person who conducted a material review and made the disposition decision did not document the material review and the disposition decision at the time of performance.

    • Returned dietary supplement - investigation (21 CFR 111.530)

      You did not conduct an investigation of your manufacturing processes, and of each other batch implicated when a dietary supplement was returned, to determine compliance with specifications.

    FEI 3002716640

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    2 citations posted:

    • Equipment - maintain - general (21 CFR 111.27(d))
    • Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))
    Full citation text
    • Equipment - maintain - general (21 CFR 111.27(d))

      You did not clean and sanitize equipment, utensils, and contact surfaces used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))

      You did not provide adequate documentation of your basis for determining that compliance with the specificatio s you selected for identity, purity, strength, and composition will ensure that the finished batch of dietary supplement meets the specificatio s.

    FEI 3002716640

Show all 9 inspections
  • No action indicated · No objectionable conditions found

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    FEI 3002716640

  • No action indicated · No objectionable conditions found

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    FEI 3002716640

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    6 citations posted:

    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))
    • Tests, examinations - scientifically valid (21 CFR 111.75(h))
    • Specifications not met - reject, quality control (21 CFR 111.77(a))
    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))
    See all 6 citations
    • Component - verify identity, dietary ingredient (21 CFR 111.75(a)(1)(i))

      You did not conduct at least one appropriate test or examination to verify the identity of a dietary ingredient, prior to its use.

    • Tests, examinations - scientifically valid (21 CFR 111.75(h))

      You did not ensure that the tests or examinations that you used to determine whether the specifications are met are appropriate, scientifically valid methods.

    • Specifications not met - reject, quality control (21 CFR 111.77(a))

      Your quality control personnel did not reject a component for which a specification was not met.

    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.

    • Laboratory operations: electronic (21 CFR 111.325(a))

      Your electronic records for your laboratory operations do not comply with the electronic records requirements.

    • Conditions, controls -protect; microorganisms, contamination (21 CFR 111.365(a))

      You did not perform manufacturing operations under conditions and controls that protect against the potential for contamination.

    FEI 3002716640

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    5 citations posted:

    • Specifications met - contamination limits (21 CFR 111.73)
    • Specifications not met - reject, quality control (21 CFR 111.77(a))
    • Written procedures - quality control operations (21 CFR 111.103)
    • Document - material review, disposition (21 CFR 111.113(c))
    See all 5 citations
    • Specifications met - contamination limits (21 CFR 111.73)

      You did not determine whether you met established limits on contamination that may adulterate, or that may lead to adulteration of, the finished batch of the dietary supplement.

    • Specifications not met - reject, quality control (21 CFR 111.77(a))

      Your quality control personnel did not reject a component for which a specification was not met.

    • Written procedures - quality control operations (21 CFR 111.103)

      You did not follow written procedures for quality control operations.

    • Document - material review, disposition (21 CFR 111.113(c))

      The person who conducted a material review and made the disposition decision did not document the material review and the disposition decision at the time of performance.

    • Returned dietary supplement - investigation (21 CFR 111.530)

      You did not conduct an investigation of your manufacturing processes, and of each other batch implicated when a dietary supplement was returned, to determine compliance with specifications.

    FEI 3002716640

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    2 citations posted:

    • Equipment - maintain - general (21 CFR 111.27(d))
    • Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))
    Full citation text
    • Equipment - maintain - general (21 CFR 111.27(d))

      You did not clean and sanitize equipment, utensils, and contact surfaces used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))

      You did not provide adequate documentation of your basis for determining that compliance with the specificatio s you selected for identity, purity, strength, and composition will ensure that the finished batch of dietary supplement meets the specificatio s.

    FEI 3002716640

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    8 citations posted:

    • Specifications met, in-process - quality finished batch (21 CFR 111.75(b)(1))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    • Specifications met - test, examinations; compliance (21 CFR 111.75(c)(2))
    • Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))
    See all 8 citations
    • Specifications met, in-process - quality finished batch (21 CFR 111.75(b)(1))

      You did not monitor the in-process points, steps, or stages, where control is necessary to ensure that the quality of the finished batch of dietary supplement, to determine whether the in-process specifications are met.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for composition.

    • Specifications met - test, examinations; compliance (21 CFR 111.75(c)(2))

      You did not conduct appropriate tests or examinations to determine compliance with the specifications established for strength and composition.

    • Specifications met identity,purity, strength, comp,; basis (21 CFR 111.75(c)(3))

      You did not provide adequate documentation of your basis for determining that compliance with the specificatio s you selected for identity, purity, strength, and composition will ensure that the finished batch of dietary supplement meets the specificatio s.

    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.

    • Manufacturing operations - prevent contamination (21 CFR 111.365)

      You did not take necessary precautions during the manufacture of a dietary supplement to prevent contamination of components.

    • Microorganism, decomposition - remove, destroy, prevent (21 CFR 111.365(e))

      You did not use effective means to remove, destroy, or prevent the growth of microorganisms and prevent decomposition.

    • Dietary supplement - protect, contamination (21 CFR 111.415(b))

      You did not protect manufactured dietary supplements from contamination during filling and packaging operations.

    FEI 3002716640

  • Voluntary action indicated · Objectionable conditions found; FDA left corrections to the firm

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    11 citations posted:

    • Equipment - automated - controls, process changes (21 CFR 111.30(d))
    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))
    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    See all 11 citations
    • Equipment - automated - controls, process changes (21 CFR 111.30(d))

      You did not use appropriate controls for automated, mechanical, or electronic equipment to ensure that changes are approved by quality control personnel and are instituted only by authorized personnel.

    • Specifications - identity, purity, strength, composition (21 CFR 111.70(e))

      You did not establish product specifications for the strength and composition of the finished dietary supplement.

    • Component - qualify supplier (21 CFR 111.75(a)(2)(ii)(A))

      You did not qualify a supplier of a component by establishing the reliability of the supplier's certificate of analysis through confirmation of the results of their tests or examinations.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for strength and composition.

    • Quality control operations - tests, examinations; results (21 CFR 111.110(c))

      Your quality control operations did not include reviewing and approving the results of required tests.

    • Quality control - batch, product specifications (21 CFR 111.123(b)(2))

      Your quality control personnel approved and released for distribution a batch of dietary supplement that did not meet established product specifications.

    • Batch record - component; identity, weight (21 CFR 111.260(e))

      Your batch production records did not include the weight or measure of each component used.

    • Examination, testing; appropriate (21 CFR 111.320(a))

      You did not verify that the laboratory examination and testing methodologies are appropriate for their intended use.

    • Records - document; results (21 CFR 111.325(b)(2)(ii))

      The documentation for laboratory tests and examinations did not include the results of the testing and examination.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold components and dietary supplements under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    • Records - original, true copies (21 CFR 111.605(b))

      You did not keep original records, true copies, or electronic records.

    FEI 3002716640

  • No action indicated · No objectionable conditions found

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    FEI 3002716640

  • Official action indicated · Regulatory or administrative action recommended

    Inspected

    Middlesex, New Jersey

    Listed by FDA as Soma Labs Inc.

    6 citations posted:

    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))
    • Cleaning compounds and toxic materials - holding (21 CFR 111.15(c)(3))
    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))
    • Specifications met - verify; finished batch (21 CFR 111.75(c))
    See all 6 citations
    • Physical plant - clean and sanitary (21 CFR 111.15(b)(1))

      You did not maintain your physical plant in a clean and sanitary condition.

    • Cleaning compounds and toxic materials - holding (21 CFR 111.15(c)(3))

      You did not identify cleaning compounds, sanitizing agents, pesticides, pesticide chemicals, or other toxic materials in a manner that protects against contamination of components, dietary supplements, or contact surfaces.

    • Equipment - maintain, clean, sanitize (21 CFR 111.27(d))

      You did not maintain equipment and utensils used to manufacture, package, label, or hold components or dietary supplements.

    • Specifications met - verify; finished batch (21 CFR 111.75(c))

      You did not verify that your finished batch of dietary supplement meets product specifications for purity, strength, and composition.

    • Reserve sample container-closure contamination,deterioration (21 CFR 111.83(b)(1))

      Your reserve sample of a dietary supplement that was distributed to be packaged and labeled was not held using a container-closure system that provides essentially the same characteristics to protect against contamination or deterioration as the one in which it was distributed for packaging and labeling elsewhere.

    • Hold - temperature, humidity, light (21 CFR 111.455(a))

      You did not hold under appropriate conditions of temperature, humidity, or light so that their identity, purity, strength, and composition are not affected.

    FEI 3002716640

We match FDA inspections to companies by facility ZIP code (or city outside the US) and company name, so an inspection filed under a different name won’t appear here. FDA publishes final classifications only, and holds some back while enforcement is pending. Posted citations may differ from FDA’s final findings. FDA Data Dashboard · How we check

What we checked, and what we didn’t

Confirmed from NSF’s public listing

Last checked

  • NSF/ANSI 455-2 GMP certification
  • 1 facility address
  • Dosage forms in the certified scope
  • Operations listed for each facility

Not verified by us

  • Minimum order quantity (MOQ): the smallest order they accept
  • Lead times and current capacity
  • Prices
  • Other certifications, like organic, kosher, halal or NSF Certified for Sport
  • Whether they’re taking new clients
  • Conditions inside the facility. We don’t visit or audit facilities.

Ask about these in your quote request. How we verify

Other capsule manufacturers in the United States

  1. NSF lists 5 capsule facilities, including one in Tempe, AZ

    Tempe, AZ, United States21stcenturyvitamins.com

    • Capsules
    • Gummies
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    NSF/ANSI 455-2checked Nov 19, 2026
  2. NSF lists a capsule facility in Centennial, CO

    Centennial, CO, United States5280smc.com

    • Capsules
    Operations:
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  3. NSF lists a capsule facility in Garden Grove, CA

    Garden Grove, CA, United Statespackaging.com

    • Capsules
    • Gummies
    • Powders
    • Softgels
    • Tablets
    NSF/ANSI 455-2checked Nov 19, 2026
  4. NSF lists a capsule facility in Ada, MI

    Ada, MI, United Statesamway.com

    • Capsules
    • Powders
    • Softgels
    • Tablets
    Operations:
    • Kitting
    • Coating
    • Tablet compression
    • Encapsulation
    • +1 more
    NSF/ANSI 455-2checked Nov 19, 2026
  5. NSF lists 2 capsule facilities, including one in Chandler, AZ

    Gilbert, AZ, United Statesadeptlifesciences.com

    • Capsules
    • Liquids
    • Powders
    • Tablets
    Operations:
    • Liquid formulation
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026
  6. NSF lists a capsule facility in Congers, NY

    Congers, NY, United Statesadhhealth.com

    • Capsules
    • Oils
    • Powders
    • Tablets
    Operations:
    • Coating
    • Tablet compression
    • Encapsulation
    • Dry formulation
    NSF/ANSI 455-2checked Nov 19, 2026